$ISOLF just put out more news showing great revenue numbers for the company plus they are talking about possible expansion into Europe and Asia.
ISODIOL INTERNATIONAL INC. JULY 2017 CORPORATE UPDATE $ISOLF
Isodiol International Inc. has released unaudited July, 2017, revenue numbers of its wholly owned subsidiary ISO International LLC of $1,358,787 (U.S.).
Marcos Agramont, chief executive officer of Isodiol, stated: "We have demonstrated another strong month of top-line revenues in what typically is a slow period of the year. Our sales and marketing teams have done an incredible job developing distributor and customer relationships which provide the company with reoccurring monthly business. In an ultracompetitive industry that is continuously evolving, we continue to establish ourselves as leaders in product quality and service. The company continues to develop and gain penetration with its pharmaceutical-grade products in Latin America and remains committed to increasing its top-line revenues and ultimately increasing its profitability. We continue to develop our infrastructure in Latin America and will begin the due diligence process of expanding into the European and Asian markets in the near future."
About Isodiol International Inc.
Isodiol International is the market leader in pharmaceutical-grade cannabis compounds and the industry leader in manufacturing and development of consumer products. Isodiol's nutraceutical division is the pioneer of many firsts for hemp-derived cannabinoids, including 99-per-cent-pure crystalline isolate, microencapsulation, and nanotechnology for the highest-quality consumable and topical skin care products.
